Advertisement
Advertisement
U.S. Markets open in 3 hrs 33 mins
Advertisement
Advertisement
Advertisement
Advertisement

Tonix Pharmaceuticals Holding Corp. (TNXP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Visitors trend2W10W9M
1.2300+0.0500 (+4.24%)
At close: 04:00PM EST
1.2300 0.00 (0.00%)
Pre-Market: 05:36AM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 2/9/2023
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.75
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 311.5200
52 Week Low 30.2900
50-Day Moving Average 30.6990
200-Day Moving Average 31.3599

Share Statistics

Avg Vol (3 month) 37.12M
Avg Vol (10 day) 32.23M
Shares Outstanding 557.54M
Implied Shares Outstanding 6N/A
Float 843.04M
% Held by Insiders 10.02%
% Held by Institutions 18.44%
Shares Short (Oct 13, 2022) 41.13M
Short Ratio (Oct 13, 2022) 40.53
Short % of Float (Oct 13, 2022) 42.12%
Short % of Shares Outstanding (Oct 13, 2022) 42.12%
Shares Short (prior month Sep 14, 2022) 41.9M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Oct 31, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Oct 31, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-26.27%
Return on Equity (ttm)-44.35%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -97.58M
Net Income Avi to Common (ttm)-101.89M
Diluted EPS (ttm)-0.5520
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)145.48M
Total Cash Per Share (mrq)3.38
Total Debt (mrq)985k
Total Debt/Equity (mrq)0.38
Current Ratio (mrq)12.05
Book Value Per Share (mrq)0.43

Cash Flow Statement

Operating Cash Flow (ttm)-87.61M
Levered Free Cash Flow (ttm)-145.81M
Advertisement
Advertisement